Lotte Advanced Materials announces new technology to help prevent healthcare associated infections

Lotte Advanced Materials introduces its new antimicrobial technology Evermoin which aims to offer safe, effective, fast acting, and durable protection against Healthcare Associated Infections (HAI).

Lotte Advanced Materials, a chemical company who specialise in polymer solutions is introducing Evermoin, a novel non-silver antimicrobial technology that claims to offer ‘built-in-the-polymer’ protection against the infection causing pathogens that cause HAI. The Evermoin technology is available in Lotte’s acrylonitrile butadiene styrene, polypropylene, and polycarbonate products.

HAI are a critical problem in hospitals and other healthcare delivery institutions. On a typical day, one out of every 25 hospital patients gets a HAI that can at best, raise the healthcare costs and, at worst can cause death to affected patients. The Evermoin antimicrobial technology hopes to help fight HAIs.

Featuring a fast acting protection against the spread of pathogens and fungal growth, the Evermoin technology has been tested to inhibit 99.9+ (3 log+) growth rate of positive and negative pathogens including Staphylococcus aureus and Escherichia coli. 

Possible medical applications include medical housings, equipment and accessories. It can also be used in non-medical applications to protect against bacterial and fungal growth in applications where cleanliness and safety are important. These include cosmetics, electrical and electronics, appliances, and kitchenware. It features excellent weatherability and ultraviolet resistance for applications where outdoor exposure may be a factor.

The Evermoin technology is non-toxic and is compliant with ISO 10993-5 and ISO 10993-10 standards. In addition it has been approved by the Food and Drug Administration (US FDA 21 CFR 181.32) and has also been approved for environmental compatibility by the Environmental Protection Agency.